207 related articles for article (PubMed ID: 36896570)
21. Alpha-1 Asthma Overlap Syndrome: a Clinical Overview.
Izquierdo M; Rawal H; Armstrong M; Marion CR
Curr Allergy Asthma Rep; 2022 Sep; 22(9):101-111. PubMed ID: 35596100
[TBL] [Abstract][Full Text] [Related]
22. Therapeutics: Gene Therapy for Alpha-1 Antitrypsin Deficiency.
Gruntman AM; Flotte TR
Methods Mol Biol; 2017; 1639():267-275. PubMed ID: 28752467
[TBL] [Abstract][Full Text] [Related]
23. Case report of a novel alpha1-antitrypsin null variant in Türkiye: Q0
Karadoğan D; Şahin Ü; Dreger B; Grandoso L; Osaba L
BMC Pulm Med; 2024 Feb; 24(1):91. PubMed ID: 38383302
[TBL] [Abstract][Full Text] [Related]
24. Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency.
Esquinas C; Janciauskiene S; Gonzalo R; Mas de Xaxars G; Olejnicka B; Belmonte I; Barrecheguren M; Rodriguez E; Nuñez A; Rodriguez-Frias F; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2017; 12():3381-3390. PubMed ID: 29238183
[TBL] [Abstract][Full Text] [Related]
25. [α1-Antitrypsin deficiency].
Hirai T
Nihon Rinsho; 2016 May; 74(5):869-73. PubMed ID: 27254961
[TBL] [Abstract][Full Text] [Related]
26. Alpha-1 antitrypsin deficiency-associated panniculitis.
Franciosi AN; Ralph J; O'Farrell NJ; Buckley C; Gulmann C; O'Kane M; Carroll TP; McElvaney NG
J Am Acad Dermatol; 2022 Oct; 87(4):825-832. PubMed ID: 33516773
[TBL] [Abstract][Full Text] [Related]
27. Pathophysiology of Alpha-1 Antitrypsin Lung Disease.
Kalfopoulos M; Wetmore K; ElMallah MK
Methods Mol Biol; 2017; 1639():9-19. PubMed ID: 28752442
[TBL] [Abstract][Full Text] [Related]
28. Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?
Beletic A; Dudvarski-Ilic A; Milenkovic B; Nagorni-Obradovic L; Ljujic M; Djordjevic V; Mirkovic D; Radojkovic D; Majkic-Singh N
Biochem Med (Zagreb); 2014; 24(2):293-8. PubMed ID: 24969923
[TBL] [Abstract][Full Text] [Related]
29. Alpha1-antitrypsin deficiency: incidence and implications.
Richmond RJ; Zellner KM
Dimens Crit Care Nurs; 2005; 24(6):255-60; quiz 261-2. PubMed ID: 16327507
[TBL] [Abstract][Full Text] [Related]
30. Alpha-1 antitrypsin deficiency.
Dasí F
Med Clin (Barc); 2024 Apr; 162(7):336-342. PubMed ID: 37993348
[TBL] [Abstract][Full Text] [Related]
31. Alpha-1-Antitrypsin Deficiency: Disease Management and Learning from Studies.
Greulich T
COPD; 2017 Mar; 14(sup1):S8-S11. PubMed ID: 28306355
[TBL] [Abstract][Full Text] [Related]
32. Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies.
Ferrarotti I; Corsico AG; Stolk J; Ottaviani S; Fumagalli M; Janciauskiene S; Iadarola P
COPD; 2017 Feb; 14(1):56-65. PubMed ID: 27827549
[TBL] [Abstract][Full Text] [Related]
33. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency.
Borel F; Tang Q; Gernoux G; Greer C; Wang Z; Barzel A; Kay MA; Shultz LD; Greiner DL; Flotte TR; Brehm MA; Mueller C
Mol Ther; 2017 Nov; 25(11):2477-2489. PubMed ID: 29032169
[TBL] [Abstract][Full Text] [Related]
34. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.
McCarthy C; Reeves EP; McElvaney NG
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S297-304. PubMed ID: 27564664
[TBL] [Abstract][Full Text] [Related]
35. Long-term experience in the treatment of α1-antitrypsin deficiency: 25 years of augmentation therapy.
Teschler H
Eur Respir Rev; 2015 Mar; 24(135):46-51. PubMed ID: 25726554
[TBL] [Abstract][Full Text] [Related]
36. Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory.
Belmonte I; Nuñez A; Barrecheguren M; Esquinas C; Pons M; López-Martínez RM; Ruiz G; Blanco-Grau A; Ferrer R; Genescà J; Miravitlles M; Rodríguez-Frías F
Int J Chron Obstruct Pulmon Dis; 2020; 15():2421-2431. PubMed ID: 33116457
[TBL] [Abstract][Full Text] [Related]
37. Recent advancements in understanding the genetic involvement of alpha-1 antitrypsin deficiency associated lung disease: a look at future precision medicine approaches.
Ghosh AJ; Hobbs BD
Expert Rev Respir Med; 2022 Feb; 16(2):173-182. PubMed ID: 35025710
[TBL] [Abstract][Full Text] [Related]
38. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.
Campos MA; Lascano J
Ther Adv Respir Dis; 2014 Oct; 8(5):150-61. PubMed ID: 25013223
[TBL] [Abstract][Full Text] [Related]
39. Alpha-1-antitrypsin deficiency.
Bals R
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):629-33. PubMed ID: 20955965
[TBL] [Abstract][Full Text] [Related]
40. Recurrence of emphysema post-lung transplantation in a patient with alpha 1 antitrypsin deficiency (AATD).
Ataya A
Respir Med Case Rep; 2020; 31():101309. PubMed ID: 33304809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
